Pieris Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
This assessment of Pieris Pharmaceuticals Inc is assembled by All Street Sevva using proprietary machine learning. This SDG score for Pieris Pharmaceuticals Inc represents its transparency towards the United Nations SDGs. This webpage is a zero-cost E,S&G assessment covering Pieris Pharmaceuticals Inc.
Pieris Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.4; made up of an environmental score of 8.0, social score of 3.2 and governance score of 8.0.
6.4
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 389 | WuXi Biologics (Cayman) Inc | 6.6 | High |
| 401 | Oxford Cannabinoid Technologies Holdings PLC | 6.5 | High |
| 402 | Pieris Pharmaceuticals Inc | 6.4 | High |
| 402 | Capricor Therapeutics Inc | 6.4 | High |
| 402 | Alembic Pharmaceuticals Ltd | 6.4 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Pieris Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Pieris Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Pieris Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Pieris Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Pieris Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Pieris Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Pieris Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Pieris Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Pieris Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Pieris Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Pieris Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Pieris Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Pieris Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Pieris Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Pieris Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Pieris Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Pieris Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Pieris Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Pieris Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Pieris Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Pieris Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Pieris Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Pieris Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Pieris Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Pieris Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Pieris Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Pieris Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Pieris Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Pieris Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Pieris Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Pieris Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Pieris Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Pieris Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Pieris Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Pieris Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Pieris Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Pieris Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anticalin-based drugs. The company develops anticalin proteins that are low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular weight human proteins found in human blood plasma and other bodily fluids. Its lead respiratory Anticalin-based drug candidate includes PRS-060/AZD1402, a drug candidate that is in Phase II clinical trial targeting IL-4Ra for the treatment of asthma and other inflammatory diseases; PRS-220, an oral inhaled Anticalin protein targeting connective tissue growth factor for the treatment of idiopathic pulmonary fibrosis; and immune-oncology program comprises Cinrebafusp alfa, a 4-1BB/ HER2 bispecific for the treatment of HER2-high and HER2-low expressing gastric cancers. The company also develops PRS-344/S095012, a bispecific anticalin-antibody fusion protein targeting 4- 1BB and PD-L1 for immuno-oncology diseases that is in phase 1 clinical trial; and PRS-352, a preclinical-stage program addressing undisclosed targets for immuno-oncology diseases. It has a license and collaboration agreement with Les Laboratoires Servier and Institut de Recherches Internationales Servier, AstraZeneca AB, and Seagen Inc.; and license agreements with Technical University of Munich, Enumeral Biomedical Holdings, Inc., and Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd. The company also has a clinical trial collaboration and supply agreement with Eli Lilly and Company. Pieris Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Boston, Massachusetts.